127 related articles for article (PubMed ID: 3519061)
21. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
Diener HC
Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
[TBL] [Abstract][Full Text] [Related]
22. [Prevention of the recurrence of episodes of cerebral ischemia. Therapeutic protocol].
Mazzei B; Carelli A; Gaudio G; Stellato G; Cundari E; Corsonello F
Minerva Med; 1988 Aug; 79(8):703-6. PubMed ID: 3405477
[No Abstract] [Full Text] [Related]
23. Combination antiplatelet agents for secondary prevention of ischemic stroke.
Vande Griend JP; Saseen JJ
Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
[TBL] [Abstract][Full Text] [Related]
24. [Preventive drug therapy of transient cerebral ischemic attacks].
Sørensen PS; Marquardsen J
Ugeskr Laeger; 1982 Aug; 144(32):2357-60. PubMed ID: 7147462
[No Abstract] [Full Text] [Related]
25. Platelet emboli and ischemia in rabbit's brain caused by ADP or arachidonic acid and the protective effect of ASA and dipyridamole.
Fieschi C; Volante F
Biochem Exp Biol; 1977; 13(3):315-9. PubMed ID: 16296015
[No Abstract] [Full Text] [Related]
26. [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
Verdecchia P
G Ital Cardiol; 1982; 12(8):598-603. PubMed ID: 6762978
[No Abstract] [Full Text] [Related]
27. [For which patient ASS, clopidogrel or dipyridamole? (interview by Dr. Med. Dirk Einecke)].
Diener HC
MMW Fortschr Med; 2004 Jun; 146(24):50. PubMed ID: 15366496
[No Abstract] [Full Text] [Related]
28. New developments in secondary stroke prevention: impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management.
Lutsep HL
J Stroke Cerebrovasc Dis; 2007; 16(6):263-7. PubMed ID: 18035244
[TBL] [Abstract][Full Text] [Related]
29. Proceedings: Prevention of ischemic cerebro vascular accident: a long term clinical trial with vasodilator and antiaggregating drugs.
Guiraud B; David J; Géraud G; Biermé R; Rascol A
Thromb Diath Haemorrh; 1975 Sep; 34(1):343-4. PubMed ID: 810915
[No Abstract] [Full Text] [Related]
30. The use of aspirin and dipyridamole in the treatment of acute ischaemic stroke/transient ischaemic attack: an audit-based discussion.
Khalil S; Mohanaruban K; Haq S
Clin Med (Lond); 2009 Apr; 9(2):196-7. PubMed ID: 19437733
[No Abstract] [Full Text] [Related]
31. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
Hankey GJ
Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
[TBL] [Abstract][Full Text] [Related]
32. [Secondary prevention after stroke. Doubled performs better].
MMW Fortschr Med; 2003 Nov; 145(46):49. PubMed ID: 14699837
[No Abstract] [Full Text] [Related]
33. Combination antiplatelet agents in ischemic cerebrovascular disease.
Moussouttas M; Papamitsakis N
Mt Sinai J Med; 2005 Jan; 72(1):16-22. PubMed ID: 15682258
[TBL] [Abstract][Full Text] [Related]
34. [ASS and dipyridamole combination. A decisive contribution to secondary prevention after stroke].
Haberl R
MMW Fortschr Med; 2003 May; 145 Suppl 2():98. PubMed ID: 14579496
[No Abstract] [Full Text] [Related]
35. Preventive treatment of cerebral transient ischemia: comparative randomized trial of pentoxifylline versus conventional antiaggregants.
Herskovits E; Famulari A; Tamaroff L; Gonzalez AM; Vázquez A; Dominguez R; Fraiman H; Vila J
Eur Neurol; 1985; 24(1):73-81. PubMed ID: 3881263
[TBL] [Abstract][Full Text] [Related]
36. A randomized double blind comparison of an aspirin dipyridamole combination versus a placebo in the treatment of necrobiosis lipoidica.
Statham B; Finlay AY; Marks R
Acta Derm Venereol; 1981; 61(3):270-1. PubMed ID: 6167117
[TBL] [Abstract][Full Text] [Related]
37. [High dosage acetylsalicylic acid administration for prevention of acute cerebral ischemia].
Hartmann A
Nervenarzt; 1995 Dec; 66(12):886-9; discussion 885. PubMed ID: 8584071
[TBL] [Abstract][Full Text] [Related]
38. MATCH results: implications for the internist.
Lutsep HL
Am J Med; 2006 Jun; 119(6):526.e1-7. PubMed ID: 16750967
[TBL] [Abstract][Full Text] [Related]
39. [Transient cerebral ischemic attacks. Treatment program and comparison between anticoagulants and thrombocyte aggregation repressors].
Burén A; Ygge J
Lakartidningen; 1979 Aug; 76(34):2784-7. PubMed ID: 529907
[No Abstract] [Full Text] [Related]
40. [Place of antiplatelet agents in the prevention of cerebral ischemic strokes].
Bousser MG
Ann Med Interne (Paris); 1983; 134(2):79-83. PubMed ID: 6349464
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
